Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 870-874

  Granoff, Dan M ^a   Gupta, Rajesh K ^b   Belshe, Robert B ^b   Andersen, Edwin L ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; MENINGOCOCCUS VACCINE; OLIGOSACCHARIDE;

ADULT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; IMMUNOREACTIVITY; INTRAMUSCULAR DRUG ADMINISTRATION; MENINGOCOCCOSIS; PRIORITY JOURNAL; VACCINATION;

EID: 0031682697     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515346     Document Type: Article

References (15)

1. Jafari HS, Perkins BA, Wenger JD. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46:1-10.
2. Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev 1997; 7: R49-54.
3. Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J Infect Dis 1996; 174: 1360-3.
4. Lieberman JM, Chiu SS, Wong VK, et al. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial. JAMA 1996; 275:1499-503.
5. Leach A, Twumasi PA, Kumah S, et al. Induction of immunological memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis 1997; 175:200-4.
6. Anderson EL, Bowers T, Mink CM, et al. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect Immun 1994; 62:3391-5.
7. Powers DC, Anderson EL, Lottenbach K, Mink CM. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J Infect Dis 1996; 173:1014-8.
8. Carlone GM, Frasch CE, Siber GR, et al. Multi-center comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol 1992; 30:154-9.
9. 197 conjugate vaccine. Infect Immun 1997; 65: 1710-5.
10. Granoff DM, Maslanka SE, Carolone GM, et al. A modified enzymelinked immunoabsorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol 1998; 5:479-85.
11. Mandrell RE, Azmi FH, Granoff DM. Complement-mediated bactericidal activity of human antibodies to poly α2 - 8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J Infect Dis 1995; 172:1279-89.
12. Goldschneider I, Lepow ML, Gotschlich EC, Mauck FT, Bachl F, Randolph M. Immunogenicity of group A and group C meningococcal polysaccharides in human infants. J Infect Dis 1973; 128:769-76.
13. Gold R, Lepow ML, Goldschneider I, Gotschlich EC. Immune response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis. J Infect Dis 1977; 136(suppl):S31-5.
14. MacDonald N, Halperin S, Law B, Forrest BD, Mokatrin A, Granoff DM. Immunization of toddlers with Chiron conjugated meningococcal C (MenC) vaccine induces immunologic memory while plain Men polysaccharide (PS) vaccine induces tolerance [abstract G-3]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Canada). Washington, DC: American Society for Microbiology, 1997.
15. Halliday WJ. Immunological paralysis of mice with pneumococcal polysaccharide antigens. Bacteriol Rev 1971; 35:267-89.